Zichron Yaakov, Israel

Einav Zeevi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Einav Zeevi in Cancer Treatment

Introduction

Einav Zeevi, an accomplished inventor based in Zichron Yaakov, IL, has made significant contributions in the field of cancer treatment through his innovative patents. With a total of two patents to his name, Zeevi is recognized for developing advanced methods that harness electrical characteristics of cancer cells to improve treatment efficacy.

Latest Patents

Zeevi's latest patents include groundbreaking advancements in Tumor Treating Fields (TTFields) therapy. His first patent focuses on determining a frequency for TTFields treatment based on the electrical characteristics of targeted cancer cells. This customizable approach allows for personalized cancer treatment by obtaining cancer cells from the subject, assessing their electrical properties, and tailoring the frequency of TTFields accordingly. Furthermore, it includes predictive elements to ascertain the effectiveness of TTFields for individual subjects before treatment commences.

His second patent involves methods and compositions that utilize sorafenib in conjunction with TTFields to treat tumors, specifically targeting hepatocellular carcinoma cells. By administering sorafenib while applying an alternating electric field with frequencies ranging from 100 to 400 kHz, the viability of these cancer cells can be significantly reduced. Experimental results have shown that this combination produces synergistic effects, enhancing treatment outcomes both in vitro and in vivo.

Career Highlights

Einav Zeevi is affiliated with Novocure GmbH, a company dedicated to the research and development of innovative cancer therapies, particularly using TTFields. His work at Novocure positions him at the forefront of cancer research, allowing him to impact patient care through cutting-edge technology and personalized medicine.

Collaborations

Zeevi collaborates with notable colleagues such as Moshe Giladi and Karnit Gotlib. These partnerships contribute to the enriching environment of innovation and research at Novocure, fostering advancements that aim to improve the lives of cancer patients.

Conclusion

Einav Zeevi's contributions to cancer treatment are marked by his inventive approach in utilizing electrical characteristics of cancer cells and combining it with pharmacological agents like sorafenib. His patents not only reflect his commitment to advancing medical technology but also represent a significant leap towards personalized cancer therapies that could offer hope to many individuals facing this daunting disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…